2015
DOI: 10.1016/j.jcin.2015.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Internal Carotid Artery Stent Implantation

Abstract: AKI in CKD patients undergoing CAS is mostly due to hemodynamic depression and is associated with a higher 30-day major adverse events rate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
32
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(35 citation statements)
references
References 38 publications
2
32
1
Order By: Relevance
“…Donahue et al 60 assessed the risk of contrast-induced nephropathy associated with carotid artery stenting. The study included 126 patients with chronic kidney disease exposed to iodixanol.…”
Section: Resultsmentioning
confidence: 99%
“…Donahue et al 60 assessed the risk of contrast-induced nephropathy associated with carotid artery stenting. The study included 126 patients with chronic kidney disease exposed to iodixanol.…”
Section: Resultsmentioning
confidence: 99%
“…The ACCF/AHA/SCAI guidelines reference using the risk score developed by Mehran et al which takes into account multiple variables including age, comorbidities, baseline renal function, hemodynamics, and CV . This risk score has been validated in multiple retrospective and prospective analyses of patients undergoing coronary angiography and interventions, percutaneous valve therapies, carotid stenting—and used to risk stratify patients enrolled in randomized controlled trials of pharmacotherapy to prevent AKI . Despite the recommendation to assess risk using such tools, it remains less certain that prospective knowledge of risk has meaningful impact on patient level outcomes in routine clinical practice.…”
Section: Discussionmentioning
confidence: 99%
“…The ACCF/AHA/SCAI guidelines reference using the risk score developed by Mehran et al which takes into account multiple variables including age, comorbidities, baseline renal function, hemodynamics, and CV [1]. This risk score has been validated in multiple retrospective and prospective analyses of patients undergoing coronary angiography and interventions, percutaneous valve therapies, carotid stenting-and used to risk stratify patients enrolled in randomized controlled trials of pharmacotherapy to prevent AKI [12][13][14][15]. Despite the recommendation to assess risk using such tools, it remains less certain that prospective knowledge of risk has meaningful impact on patient level outcomes in routine clinical practice.…”
Section: Risk Assessmentmentioning
confidence: 99%